Nuvaring and Ocrevus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nuvaring (ethinyl estradiol; etonogestrel) and Ocrevus (ocrelizumab). Common drug interactions include fatigue among females.

The phase IV clinical study analyzes what interactions people have when they take Nuvaring and Ocrevus. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Nuvaring?

Nuvaring has active ingredients of ethinyl estradiol; etonogestrel. It is often used in birth control. eHealthMe is studying from 28,730 Nuvaring users. Check the latest studies of Nuvaring.

What is Ocrevus?

Ocrevus has active ingredients of ocrelizumab. eHealthMe is studying from 56,583 Ocrevus users. Check the latest studies of Ocrevus.

On Jul, 11, 2026

20 people who take Nuvaring and Ocrevus together, and have interactions are studied.

What are the common drug interactions of Nuvaring and Ocrevus, by gender? *:

female:

Fatigue (feeling of tiredness)
Headache (pain in head)
Heart rate increased
Pain in extremity
Nausea (feeling of having an urge to vomit)
Abdominal pain upper
Dry eye (lack of adequate tears)
Dyspnoea (difficult or laboured respiration)
Visual impairment
Rash

male:

n/a

What are the common drug interactions of Nuvaring and Ocrevus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Fatigue (feeling of tiredness)
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Mood swings (an extreme or rapid change in mood)
Nasopharyngitis (inflammation of the nasopharynx)
Throat irritation
Asthenia (weakness)
Cough
Diarrhoea
Heart rate increased

30-39:

Facial pain
Food poisoning (poison in food)
Gingival swelling (gums swelling)
Headache (pain in head)
Herpes zoster
Maternal exposure before pregnancy (use of substance before pregnancy)
Rash
Urinary tract infection
Abdominal discomfort
Anxiety

40-49:

Fatigue (feeling of tiredness)
Abdominal discomfort
Nausea (feeling of having an urge to vomit)
Oropharyngeal pain
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pharyngitis (inflammation of the pharynx, causing a sore throat)
Pruritus (severe itching of the skin)
Rash
Infusion related reaction
Anxiety

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 16 people, 80.00%
Neuralgia (pain in one or more nerves): 2 people, 10.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 10.00%
Dysmenorrhea (painful menstruation): 2 people, 10.00%
Stress And Anxiety: 1 person, 5.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 5.00%
Nausea (feeling of having an urge to vomit): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nuvaring and Ocrevus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously